Recent Filings (6)

• Feb 17, 2026Form 4Enliven Therapeutics, Inc.+17,126 sh
• Aug 28, 2025Form 4BridgeBio Oncology Therapeutics, Inc.+138,193 sh
• Aug 18, 2025Form 3BridgeBio Oncology Therapeutics, Inc.
• May 5, 2025Form 4Immunovant, Inc.+60,250 sh
• Apr 28, 2025Form 3Immunovant, Inc.
• Feb 10, 2025Form 4Enliven Therapeutics, Inc.+20,491 sh